
MSD, known as Merck in the United States and Canada, has announced that it will acquire clinical-stage biotechnology company Pandion …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

